ECRAID-Prime European Clinical Research Alliance on Infectious Diseases: Primary care adaptive platform trial for pandemics and epidemics. Updates Study Tags (field_study_tags) - Any - ADEQUATE BE READY NOW Blog Call-outs CLIN-Net CoMeCT COVID-19 Data Ecraid ECRAID-Base Education EPI-Net EPOXI Interview Mpox NeoDeco NOFLU Partners People PIPELINE POS-ARI-ER POS-ARI-PC POS-cUTI POS-Disease X POS-VAP Primary Care PrIMAVeRA PRUDENCE RECLAIM RECOVERY REMAP-CAP SNAP SOS Covid Training Vaccines 26.02.2026 ECRAID-Prime and Oxford’s Primary Care Trials Unit Take Randomised Controlled Trials to the People The trial has recently launched remote participant recruitment in the UK. 23.10.2025 Primary Care Platform Trial for Respiratory Infections Launches Third Treatment Arm 4.09.2025 ECRAID-Prime Trains for Third Treatment in Adaptive Platform Trial 22.05.2025 From Collaboration to Preparedness: Strengthening Clinical Research in Primary Care National coordinating teams from 10 countries meet in Utrecht. 30.04.2025 ECRAID-Prime expands trial with new antiviral treatment New LTX-109 intranasal spray will be added to ongoing adaptive platform trial in primary care. 27.03.2025 ECRAID-Prime Welcomes Georgia: Latest Study Milestones & Updates The study’s newest country enrols its first patient Load More
ECRAID-Prime European Clinical Research Alliance on Infectious Diseases: Primary care adaptive platform trial for pandemics and epidemics.
26.02.2026 ECRAID-Prime and Oxford’s Primary Care Trials Unit Take Randomised Controlled Trials to the People The trial has recently launched remote participant recruitment in the UK.
22.05.2025 From Collaboration to Preparedness: Strengthening Clinical Research in Primary Care National coordinating teams from 10 countries meet in Utrecht.
30.04.2025 ECRAID-Prime expands trial with new antiviral treatment New LTX-109 intranasal spray will be added to ongoing adaptive platform trial in primary care.
27.03.2025 ECRAID-Prime Welcomes Georgia: Latest Study Milestones & Updates The study’s newest country enrols its first patient
